Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since. 

Share:
More In Science
Need2Know: February 16, 2023
One people killed in a shooting in El Paso, Ohio residents are worried about health issues after a serious train derailment, and there has been a decrease in overdose deaths in the U.S. Here is everything you Need2Know for Thursday, February 16, 2023.
Load More